In recognition of his dedicated service to our Board and Alpha-1 Community, AlphaNet is proud to honor Immediate Past Chair Robert (Bob) L. Greene, Jr. with a $100,000 donation to the Alpha-1 Foundation. This donation will help fund Alpha-1 testing and detection efforts and make a difference to individuals who will benefit from knowing their Alpha-1 Antitrypsin Deficiency diagnosis earlier.
“It is so fitting to honor Bob with a donation that supports testing and detection. For more than a decade, he has been committed to putting Alphas first. He has built upon AlphaNet’s many strengths to foster partnerships that help us provide innovative health management and customized care to improve the lives of Alphas from their time of detection onward. His leadership is also one of the reasons AlphaNet has been able to contribute more than $70 million toward research for better treatments and a cure,” AlphaNet Board Chair Dell Witcher said.
“Thank you, Bob, for your decade-long commitment as AlphaNet Board Chair. We are grateful for your leadership in the Alpha-1 community. What an incredible way for AlphaNet to honor your dedication with this $100,000 gift for Alpha-1 testing and detection to the Alpha-1 Foundation! A gift that will lead many Alphas to earlier diagnosis and improved quality of life,” Alpha-1 Foundation President and CEO Scott Santarella said.
Bob joined the AlphaNet board in 2007 and served as Board Chair from 2014-2024. He currently serves as Board Chair of AlphaNet Canada, a non-profit dedicated to providing comprehensive disease management services to individuals in Canada with alpha-1 antitrypsin deficiency.
Bob was self-diagnosed in 2002 by way of the internet where he found the websites for the Alpha-1 Foundation and AlphaNet. Bob’s only clue was an earlier diagnosis of lung disease after 7 years of symptoms and two doctors telling him he needed to exercise. The American Lung Association website had one sentence stating that 5% of COPD cases were caused by Alpha-1 Antitrypsin Deficiency. Upon seeing this, Bob called a pulmonologist and was referred to and requested a blood test. Officially, Bob discovered AlphaNet two weeks before a diagnosis of Alpha-1 Antitrypsin Deficiency. Joyce Finch was Bob’s first AlphaNet Coordinator.
Bob worked as an Industrial Engineer and then founded Robert L. Greene, Jr., Associates where he worked as a Financial Advisor for 27 years.
